芬兰老年髋部骨折患者骨折前血清25-羟基维生素D水平与生存率的关系
该研究基于芬兰两家医院245例髋部骨折患者的前瞻性队列,随访至少3.2年,发现骨折前血清25-羟基维生素D水平为50-74 nmol/L的患者3年生存率最高、死亡率最低,该水平低于髋部骨折患者推荐的25-羟基维生素D水平。
要点
- 骨折前25-羟基维生素D 50-74 nmol/L与最低3年死亡率和最高生存率相关。
- 年龄<85岁、居家居住、ASA 1-2级和3级、女性也是生存的重要因素。
- 该结果不同于类似研究,且低于推荐的25-羟基维生素D水平,需更大样本验证。
核心结论
- 骨折前血清25-羟基维生素D水平为50-74 nmol/L的患者3年生存率最高、死亡率最低。
研究设计与样本
- 前瞻性收集的芬兰两家医院245例髋部骨折患者队列,其中70%为女性,随访至少3.2年。
- 入院时测量血清25-羟基维生素D,分为<50、50-74、75-99和≥100 nmol/L四组。
- 采用贝叶斯多变量模型分析生存,用寿命表法探索相对生存。
主要发现
- 血清25-羟基维生素D 50-74 nmol/L组患者在每个骨折后年份的死亡率均显著低于所有其他患者合计。
- 生存的最重要因素包括年龄<85岁、居住在实际/私人住宅、血清25-羟基维生素D 50-74 nmol/L(其次75-99 nmol/L)、ASA 1-2级和3级以及女性。
- 血清25-羟基维生素D 50-99 nmol/L患者的平均年龄显著高于其他水平组。
- 相对生存率在男性、女性及B医院患者中均以血清25-羟基维生素D 50-74 nmol/L组最高。
关键数值与推荐
- 血清25-羟基维生素D分组界值:<50、50-74、75-99、≥100 nmol/L。
- 骨折前血清25-羟基维生素D 50-74 nmol/L与最低3年死亡率相关。
- 该水平低于髋部骨折患者推荐的25-羟基维生素D水平。
临床怎么用
- 对于老年髋部骨折患者,评估骨折前血清25-羟基维生素D水平可能有助于识别生存风险。
- 血清25-羟基维生素D 50-74 nmol/L与最高生存率相关,但该水平低于推荐水平,临床决策需结合其他因素。
局限性
- 结果不同于类似研究,需未来更大样本数据验证。
- 样本来自芬兰两家医院,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The association between serum 25-hydroxyvitamin D level and post-fracture mortality indicates beneficial relatively high serum 25-hydroxyvitamin D concentrations. A 1-year cohort study on 245 hip fracture patients in Finland indicated the lowest 3-year mortality and highest survival among patients with serum 25-hydroxyvitamin D level of 50-74 nmol/L. PURPOSE: To explore pre-fracture serum 25-hydroxyvitamin D level as a factor associated with post-fracture survival among a cohort of hip fracture patients in Finland. METHODS: A prospectively collected cohort of hip fracture patients (n = 245, 70% women) from two hospitals was followed for 3.2 post-hip fracture years. Serum 25-hydroxyvitamin D was measured in admission to the hospital and classified: < 50, 50-74, 75-99, and ≥ 100 nmol/L. Survival was analyzed with a Bayesian multivariate model. Relative survival was explored with the life table method according to serum 25-hydroxyvitamin D. Mortality according to serum 25-hydroxyvitamin D level and to the hospital was calculated. RESULTS: Mortality in the patients with serum 25-hydroxyvitamin D level of 50-74 nmol/L was significantly lower than in all other patients together at every post-fracture year. The most important factors for survival were age under 85 years; living in an actual/private home; serum 25-hydroxyvitamin D level of 50-74 nmol/L, followed by 75-99 nmol/L; ASA classes 1-2 and 3; and female sex. The mean age of patients with serum 25-hydroxyvitamin D level of 50-99 nmol/L was significantly higher than in other levels. Relative survival was highest in men, women, and patients in hospital B with serum 25-hydroxyvitamin D level of 50-74 nmol. CONCLUSION: The highest 3-year survival and the lowest mortality in this cohort appeared in patients with pre-fracture serum 25-hydroxyvitamin D level of 50-74 nmol/L. This result differs from similar studies and is lower than the recommended level of 25-hydroxyvitamin D among hip fracture patients. The results should be examined in future research with larger data.
引用
- Nurmi-Lüthje I, Tiihonen R, Paattiniemi EL, et al. Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up. Osteoporos Int. 2021. PMID: 34591132. doi:10.1007/s00198-021-06094-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。